SM

Sonalben Mistry

Active Director Designated Partner DIN 11533539
DIN 11533539 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sonalben Mistry

Data last updated:

Sonalben Mistry is a Designated Partner at Asepticore Pharmaceuticals Llp (since 2026). The company operates in Pharma.

DIN 11533539
Primary Designation Designated Partner
Industry Pharma
First Appointment 09 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner09 Feb 20262026Active

Board colleagues of Sonalben Mistry

NameDINCompanyDesignation
Pandya Gautami11533540Asepticore Pharmaceuticals LlpDesignated Partner
Rajni Aashish Nair11533538Asepticore Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Asepticore Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Sonalben Mistry

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonalben Mistry

Sonalben Mistry currently holds 1 directorship: Asepticore Pharmaceuticals Llp (Designated Partner, since 09 Feb 2026).

Sonalben Mistry was first appointed on 09 Feb 2026 as Designated Partner at Asepticore Pharmaceuticals Llp.

The current boards of Sonalben Mistry's companies include Pandya Gautami (Asepticore Pharmaceuticals Llp), Rajni Aashish Nair (Asepticore Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available